DJIA 18,096.90 -106.47 -0.58%
NASDAQ 4,967.14 -12.76 -0.26%
S&P 500 2,098.53 -9.25 -0.44%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

57.88 -0.46 (-0.79%)

REAL-TIME: Last trade at

Extended Hours: $57.88 $0.00 (0.00%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

MRK $57.88 -0.79%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $58.41
Previous Close $58.34
Daily Range $57.68 - $58.65
52-Week Range $52.49 - $63.62
Market Cap $164.3B
P/E Ratio 14.33
Dividend (Yield) $1.80 (3.1%)
Ex-Dividend Date
Dividend Pay Date
03/12/15
04/08/15
Volume 13,334,541
Average Daily Volume 9,963,056
Current FY EPS $3.42

Sector

Healthcare

Industry

Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary Rss Feed

Billionaire George Soros Just Dumped These 3 Dividend Stocks

Controversial hedge fund tycoon George Soros just sold three top dividend stocks. Should you follow his lead?

Geron's Q4 Loss Narrows Y/Y, Announces Restructuring Plan - Analyst Blog

Bristol-Myers Squibb’s $1.6 Billion On New Drug Deals Is Well Spent

Merck’s Partnership With NGM Is A Bold Move

Fast Money Picks For March 2

This Billionaire CEO Just Made Another Biotech Acquisition -- and Hardly Anyone Noticed

Intrexon, led by biotech billionaire R.J. Kirk, acquired a little known Belgian biotech. Is it a big deal for investors?

Which Cancer Immunotherapy Will Be the Most Successful?

Motley Fool experts discuss whether Bristol-Myers Squibb's Opdivo or Merck & Co.'s Keytruda will be the bigger commercial success.

Bayer Q4 Net Income Down Y/Y, Provides 2015 Outlook - Analyst Blog

Dow Jones (DJIA) Today: Merck (MRK) Lower

Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers

See More MRK News...

MRK's Top Competitors

MRK $57.88 (-0.79%)
Current stock: MRK
JNJ $101.65 (-0.67%)
Current stock: JNJ
NVS $99.04 (-0.02%)
Current stock: NVS
RHHBY $33.15 (-0.91%)
Current stock: RHHBY